Amgen Inc. (AMGN) fundamentals score
Amgen Inc. discovers, develops, manufactures and delivers innovative medicines to fight some of the world’s toughest diseases. It focuses on areas of high unmet medical need and leverage its expertise to strive for solutions that dramatically improve people’s lives, while also reducing the social and economic burden of disease.
Biological Products, (No Diagnostic Substances) · Healthcare · Listed on NASDAQ
Overall: 7.3 out of 10, Good long-term fundamentals
- Growth: 6.4/10
- Profitability: 8.8/10
- Financial health: 6.7/10
- Earnings quality: 8.5/10
- Valuation: 6.1/10
Scores are calculated from Amgen Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10